SUMMARY Clinical and laboratory measures of disease expression were compared within and between 33 families with two or more affected siblings with rheumatoid arthritis (RA). None of the variables studied-age and calendar year of disease onset, pattern of joint involvement, the presence of rheumatoid nodules, Sjogren's syndrome, a positive latex or antinuclear antibody (ANA) titre-showed a greater concordance within the families than between them. The families were then divided into those in which the affected sibling pairs were and were not HLA identical. Such a division did not alter the conclusion, with the possible exception of a positive latex titre. These results suggest that genetic or unique environmental factors within families may have only a limited role in explaining disease heterogeneity in RA. Conversely, the absence of homogeneity within the families justifies their use in genetic linkage studies and the extrapolation of results obtained from affected siblings to the commoner sporadic disease.
The existence of a genetic component in rheumatoid arthritis (RA) is supported by evidence of clustering of disease in families,' with a greater concordance in monozygotic than dizygotic twins.2 Recent studies of HLA antigens in affected and non-affected unrelated individuals have shown an association between HLA-DR4/Dw4 and RA, suggesting that genetic factors may be important in sporadic cases.3 4 The disease shows considerable heterogeneity in its clinical expression and one obvious explanation for this could be that the genetic component in aetiology varies between disease subgroups. Thus patients with seropositive RA are more likely to have a family history' and be HLA-DR4 positive-7; though the latter is not a universal finding.4 Most patients with RA have no family history, suggesting a multifactorial disease aetiology. The relative influence of genetic and environmental factors is unknown but may vary in different subgroups of RA. The existence in a family of two or more affected members with RA suggests that a shared genetic or environmental factor, or both, may be responsible, at least in part, for their susceptibility to the disease.
Accepted for publication 7 July 1986. Correspondence to Dr Alan J Silman. Department In this report the hypothesis is tested that the pattern of disease expression within these families is shaped by the same factors determining their disease susceptibility. If the hypothesis were true similarity in certain aspects of disease expression might be expected. The absence of such observed similarity would argue against disease expression being strongly linked genetically within families. This question is of practical importance to those using multicase families as a tool for examining linkage with specific genetic markers. Greater disease homogeneity within, rather than between, affected families would suggest that conclusions about any linkage observed could not be extrapolated generally.
We have compared disease heterogeneity within and between affected members of families with multiple cases of RA. The analysis is restricted to affected siblings to exclude bias due to differences in disease duration between generations.
Patients and methods
We have investigated 27 The concordance between the sibling trios could be handled separately from that between the pairs. For the dichotomous variables, whatever the prevalence, at least two individuals of the trio must be concordant. Thus treating a trio (A,B,C) as three pairs (AB, AC, BC) would perhaps weight the results towards a greater concordance. In practice the difference between the observed and expected concordance in the trios was similar whether analysed as 'n' trios or as three 'n' sibling pairs. In the latter case the six trios generated 18 sibling pairs, which were analysed jointly with the 27 other pairs.
Finally, the concordance within families for the continuous variables was studied using the F test for a two way analysis of variance.
Results
Within the sibling pairs there was a mean difference in age of RA onset of 14-3 years (SD 11*7, range 1-61), and the variation within pairs was not significantly less than that between pairs (F=0-78). Similarly, there was a mean difference in calendar year of disease onset of 14-8 years (SD 13-5, range 1-59), and again the variation within pairs was not significantly less than that between pairs (F=0.49).
Each pair had at least one individual with at least one of the two joint groups (MCP/carpus) involved, and in half the pairs both joint groups were involved in both individuals (Table 1) . Interestingly, there was only one pair in which neither individual had both joint groups involved. 
Failure to find disease similarity in sibling pairs with RA 137 The agreement for nodules was poor (Table 2 ) (x=-0-08, p NS), with most pairs (26) being discordant. Similarly, Sjogren's syndrome, when present, was normally discordant between the pairs (x= -0*01, p NS). Perhaps surprisingly there was no concordance for a positive latex titre (1/80 or above), with the distribution within pairs being that expected by chance (x=0-00, p NS) ( Table 3) . A similar observation was seen with ANA with a titre of 1/10 or above (x=0.04, p NS) ( Table 3 ). For each of the above four variables the upper 95% confidence limit was below 0-45, thereby excluding the likelihood of important concordance (see above).
The pairs were then separated into the 17 HLA identical (sharing two haplotypes) and 28 nonidentical pairs (sharing one or no haplotype). The percentage congruence within the pairs (i.e., the proportion of the pairs within that group with both in the pair either positive or negative for a given variable) for the presence of nodules, Sjogren's syndrome, a positive latex or positive ANA titre was 
Discussion
There was no evidence of greater disease heterogeneity between the families than between affected individuals within the families. Thus if there were aetiological differences between the families these differences were not reflected clinically or in the laboratory tests employed. More specifically the clinical features ascertained in this study were not related to the presumed shared genetic or environmental factors, or both, that led to disease susceptibility in affected family members. The presence of HLA haplotype sharing between affected members did not alter the above conclusion. Thus HLA haplotype was not associated with disease heterogeneity in these families and was not associated with any specific disease subgroups. The results from the latex test may be an exception, but a larger study would be necessary to show whether or not affected members who shared HLA haplotypes were more likely to be congruent for a positive latex titre than other families with partial or no sharing.
There are three caveats in interpreting these data. Firstly, there might have been treatment differences between the affected members within a family; there is insufficient information to answer this. The presence of Sjogren's syndrome, nodules, ANA positivity, and the pattern of joint involvement (the variables used in this study) are less likely to be affected by treatment, however, than are variables indicating joint inflammation or functional ability. Secondly, these data were collected at only one time and therefore recorded only current and past disease expression. It might be, for example, that follow up would show more cases of Sjogren's syndrome or an altered pattern of joint involvement. It is unlikely, however, that the cross sectional approach selectively under-recorded the presence of disease attributes in the discordant as opposed to the negatively concordant pairs. In addition, the overall rate for nodules of 43% and seropositivity of 72% do not suggest underascertainment compared with standard descriptions of the disease. 12 Thirdly, the analysis of the 'n' trios as '3n' pairs might, as stated earlier, bias the results towards greater concordance. In fact this potential bias would operate against the direction of the observed results and hence strengthen the conclusions on nonconcordance.
The failure to find homogeneity within families for each age or calendar year of onset merits attention. A similar age of onset within pairs would have supported a shared genetic susceptibility, whereas a similar calendar year of onset would have supported a shared environmental influence. The absence of either does not exclude a similar multifactorial inheritance within the sib pairs but does suggest that the cause of RA in these families is complex and hence unlikely to be explained by simple combinations of identified genetic and environmental factors. It is accepted that there might be error in the recalled date of onset, especially in those with disease of long duration. It is unlikely that such an error would either be selective in producing relatively greater discordance between pairs or numerically large enough to affect the results to any important extent.
In conclusion, genetic factors may have only a limited role in explaining disease heterogeneity in RA. Thus the identification of clinical subgroups is unlikely to be informative in unravelling the complex genetic background of RA. Finally, in view of these observations families with multiple cases of rheumatoid arthritis may not be a biased tool for investigating linkage between genetic markers and disease in the general population.
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